Trial Profile
Phase IV Study of Enteric-Coated Mycophenolate Sodium in Combination With Tacrolimus in Renal Transplant Patient.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Feb 2017
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Adverse reactions
- Sponsors Novartis
- 07 May 2012 Actual end date (December 2008) added as reported by ClinicalTrials.gov.
- 10 Jun 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jun 2009 Actual number of patients (18) added as reported by ClinicalTrials.gov.